GRDN (Guardian Pharmacy Services) Beneish M-Score: -2.74 (As of Jul. 12, 2026)


GRDN Guardian Pharmacy Services Inc GRDN
42 GF Score
Price $40.96
! 4 Warning Signs
View Full Analysis

What is Guardian Pharmacy Services Beneish M-Score?

Guardian Pharmacy Services GRDN -0.24% 42 Beneish M-Score is -2.74 as of Jul. 12, 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 62.86% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.74 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Guardian Pharmacy Services's Beneish M-Score or its related term are showing as below:

GRDN' s Beneish M-Score Range Over the Past 10 Years
Min: -4.36   Med: -2.94   Max: -2.73
Current: -2.74

During the past 8 years, the highest Beneish M-Score of Guardian Pharmacy Services was -2.73. The lowest was -4.36. And the median was -2.94.


Guardian Pharmacy Services Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Guardian Pharmacy Services's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardian Pharmacy Services Beneish M-Score Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 -2.90 -3.05 -4.36 -2.97

Guardian Pharmacy Services Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4.20 -2.77 -2.97 -2.74

GRDN vs ACHC, ASTH, NHC: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Guardian Pharmacy Services's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardian Pharmacy Services Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Guardian Pharmacy Services's Beneish M-Score falls into.


GRDN
42GF Score
Guardian Pharmacy Services Inc GRDN
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardian Pharmacy Services Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Guardian Pharmacy Services for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.01+0.528 * 0.9451+0.404 * 0.8863+0.892 * 1.1354+0.115 * 1.0111
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6427+4.679 * -0.088043-0.327 * 0.8905
=-2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $112 Mil.
Revenue was 336.595 + 397.616 + 377.427 + 344.334 = $1,456 Mil.
Gross Profit was 76.309 + 85.502 + 74.721 + 68.146 = $305 Mil.
Total Current Assets was $235 Mil.
Total Assets was $427 Mil.
Property, Plant and Equipment(Net PPE) was $91 Mil.
Depreciation, Depletion and Amortization(DDA) was $23 Mil.
Selling, General, & Admin. Expense(SGA) was $227 Mil.
Total Current Liabilities was $161 Mil.
Long-Term Debt & Capital Lease Obligation was $30 Mil.
Net Income was 13.295 + 20.923 + 9.818 + 9.03 = $53 Mil.
Non Operating Income was 0.772 + 0.5 + 0.437 + 0.179 = $2 Mil.
Cash Flow from Operations was 6.062 + 34.6 + 28.169 + 19.936 = $89 Mil.
Total Receivables was $97 Mil.
Revenue was 329.308 + 338.569 + 314.393 + 300.037 = $1,282 Mil.
Gross Profit was 64.349 + 67.104 + 60.878 + 61.288 = $254 Mil.
Total Current Assets was $166 Mil.
Total Assets was $334 Mil.
Property, Plant and Equipment(Net PPE) was $79 Mil.
Depreciation, Depletion and Amortization(DDA) was $20 Mil.
Selling, General, & Admin. Expense(SGA) was $311 Mil.
Total Current Liabilities was $145 Mil.
Long-Term Debt & Capital Lease Obligation was $22 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(111.704 / 1455.972) / (97.409 / 1282.307)
=0.076721 / 0.075964
=1.01

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(253.619 / 1282.307) / (304.678 / 1455.972)
=0.197783 / 0.209261
=0.9451

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (235.184 + 90.888) / 426.941) / (1 - (166.044 + 78.921) / 333.998)
=0.23626 / 0.266567
=0.8863

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1455.972 / 1282.307
=1.1354

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(20.288 / (20.288 + 78.921)) / (23.044 / (23.044 + 90.888))
=0.204498 / 0.202261
=1.0111

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(227.307 / 1455.972) / (311.467 / 1282.307)
=0.15612 / 0.242896
=0.6427

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((29.665 + 160.543) / 426.941) / ((21.793 + 145.297) / 333.998)
=0.445514 / 0.500272
=0.8905

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(53.066 - 1.888 - 88.767) / 426.941
=-0.088043

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Guardian Pharmacy Services has a M-score of -2.74 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.74 mean?
Guardian Pharmacy Services (GRDN) has a Beneish M-Score of -2.74 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guardian Pharmacy Services and its competitors. According to the industry distribution chart, Guardian Pharmacy Services ranks #234 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 37.1%.
Is Guardian Pharmacy Services' Beneish M-Score too high?
Guardian Pharmacy Services' current Beneish M-Score is -2.74. Based on the distribution chart, Guardian Pharmacy Services ranks #234 out of 630 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Beneish M-Score compare to ACHC and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #234 out of 630 companies for Beneish M-Score. This puts Guardian Pharmacy Services in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Guardian Pharmacy Services and its competitors. Guardian Pharmacy Services's current Beneish M-Score is -2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Beneish M-Score of -2.74. The current Beneish M-Score is -2.74. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Beneish M-Score is -2.74 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guardian Pharmacy Services Business Description

Address 300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score

Get the complete analysis for GRDN

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.96
Price